Press Releases

To schedule a media interview with Arun Menawat, Chief Executive Officer, a urologist or a patient, please contact:

Stephen Kilmer
Investor Relations
647.872.4849 (Canada)
646.274.3580 (U.S)

Aaron Davidson
CFO and SVP of Corporate Development
647.476.1350

Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues
January 3, 2019, Press Release

Profound Medical Announces Changes to Commercial Organization
December 14, 2018, Press Release

Profound Medical Announces Third Quarter 2018 Financial Results
November 8, 2018, Press Release

Profound Medical to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum
November 8, 2018, Press Release

Profound Medical to Present at the Stifel 2018 Health Conference 
November 7, 2018, Press Release

Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow
October 30, 2018, Press Release

3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018
September 18, 2018, Press Release

Profound Medical Files Preliminary Base Shelf Prospectus
September 6, 2018, Press Release

Profound Medical Announces Second Quarter 2018 Financial Results
August 14, 2018, Press Release

Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow
August 2, 2018, Press Release

Profound Medical Present at the Canaccord Genuity 38th Annual Growth Conference
July 31, 2018, Press Release

Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking
July 31, 2018, Press Release

Profound Medical Corp. Announces Graduation to Toronto Stock Exchange
July 11, 2018, Press Release

Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
June 14, 2018, Press Release

Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
May 21, 2018, Press Release

Profound Medical Corp. Announces First Quarter 2018 Financial Results
May 10, 2018, Press Release

Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve
May 9, 2018, Press Release

Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
May 2, 2018, Press Release

Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
May 1, 2018, Press Release

Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
April 25, 2018, Press Release

Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales & Marketing Function
April 23, 2018, Press Release

Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results
March 26, 2018, Press Release

Profound Medical Corp. Announces Closing of Bought Deal Financing
March 20, 2018, Press Release

Profound Medical to Release Fourth Quarter and Full Year 2017 Financial Results on March 26, 2018 – Conference Call to Follow
March 9, 2018, Press Release

Profound Medical Corp. Upsizes Previously Announced Bought Deal Financing
February 28, 2018, Press Release

Profound Medical Corp. Announces $20 Million Bought Deal Financing
February 27, 2018, Press Release

Profound Medical to Participate in 2018 BTIG Healthcare Conference
February 26, 2018, Press Release

Profound Medical Corp.  Announces Completion of Patient Enrollment in  TACT Pivotal Clinical Trial
January 31, 2018, Press Release

Profound Medical Corp.  Announces Preliminary Fourth Quarter 2017 Revenue & Provides Progress Update on TACT Pivotal Trial Patient Enrollment  
January 8, 2018, Press Release

Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference

November 14, 2017, Press Release

Profound Medical Corp. Announces Third Quarter 2017 Financial Results

November 7, 2017, Press Release

Profound Medical Corp. Announces Expanded Clinical Use of TULSA-PRO® in Prostate Care to Include BPH

November 6, 2017, Press Release

Profound Medical Corp. to present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Form

October 26, 2017, Press Release

Profound Medical Corp. to Release Third Quarter 2017 Financial Results on    November 7, 2017 – Conference Call to Follow

October 25, 2017, Press Release

Profound Medical Corp. Announces Closing of $10 Million “Bought Deal” Financing

September 20, 2017

Profound Medical Corp. Announces $10 Million “Bought Deal” Financing

August 24, 2017

Profound Medical Announces Second Quarter 2017 Financial Results

August 23, 2017

Profound Medical Corp. to Release Second Quarter 2017 Financial Results on August 23, 2017 – Conference Call to Follow

August 9, 2017

Profound Medical Corp. Completes Acquisition of Royal Philips’ Sonalleve MR-HIFU Business

July 31, 2017

Profound Medical Corp. Announces Definitive Agreement with Royal Philips to Expand Collaboration and Acquire Sonalleve MR-HIFU Business

June 30, 2017

Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results

May 24, 2017

Profound Medical Corp. Announces First Quarter 2017 Financial Results

May 9, 2017

Profound Medical to Present at the CIBC Technology & Innovation Conference 5.0

May 3, 2017

Profound Medical Corp. to Release First Quarter 2017 Financial Results on May 9, 2017 – Conference Call to Follow

April 25, 2017

Profound Medical Corp. Obtains DTC Eligibility for its Common Shares in the U.S.

April 18, 2017

Profound Medical Corp. Announces First Paid Procedure Using TULSA-PRO® System

March 27, 2017

Profound Medical Corp. Announces Management Change

March 24, 2017

Profound Medical Corp. and Philips Announce first TULSA-PRO® Sale in Finland to Turku University Hospital

March 20, 2017

Profound Medical Corp. to Begin Trading on OTCQX on March 13, 2017

March 9, 2017

Profound Medical Corp. Announces Fourth Quarter and Full Year 2016 Financial Results

March 6, 2017

Profound Medical Corp. to Release Fourth Quarter and Full Year 2016 Financial Results on March 6, 2017 – Conference Call to Follow

February 21, 2017

Profound Medical to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference

February 14, 2017

Profound Medical Announces Special Meeting of Shareholders Voting Results

January 26, 2017

Profound Medical Announces Appointment of Kenneth Galbraith to its Board of Directors

January 17, 2017

Profound Medical Corp. Announces Third Quarter 2016 Financial Results

November 16, 2016

Profound Medical Corp. Completes Previously Announced $17.4 Million Bought Deal Offering of Common Shares

November 14, 2016

Profound Medical Corp. to Present at the 2016 Canaccord Genuity Medical Technologies & Diagnostic Forum

November 3, 2016

Profound Medical Corp. to Present at the Stifel 2016 Healthcare Conference

November 1, 2016

Profound Medical Corp. to Release Third Quarter 2016 Financial Results on November 16, 2016 – Conference Call to Follow

October 26, 2016

Profound Medical Corp. Announces $17.4 Million Bought Deal Financing

October 17, 2016

Profound Medical Receives Frost & Sullivan’s 2016 New Product Innovation Award

October 5, 2016

Profound Medical Corp. Announces First Patient Treated in TACT Pivotal Clinical Trial at Vanderbilt University Medical Center

September 22, 2016

Profound Medical Corp. Announces Second Quarter 2016 Financial Results

August 18, 2016

Profound Medical Corp. Announces Senior Management Changes to Support Global Growth Strategy 

August 15, 2016

Profound Medical Corp. to Release Second Quarter 2016 Financial Results on August 18, 2016

August 10, 2016

Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results

June 22, 2016

Profound Medical Corp. and Philips Sell TULSA-PROTM System to Cologne, Germany

June 21, 2016

Profound Medical Corp, and Philips Sell TULSA-PROTM System to UCL and UCLH

June 20, 2016

Profound Medical Corp. to hold Annual General Meeting of the Shareholders

June 7, 2016

FDA Grants Profound Medical Corp. IDE Approval for TULSA-PROTM

May 19, 2016

Profound Medical Corp. and Philips sign Sales and Marketing Agreement in MRI-guided therapy for Prostate Cancer Care

May 11, 2016

Profound Medical Corp. Announces First Quarter 2016 Financial Results

May 6, 2016

Profound Medical Corp. to Present at Upcoming Conference 

April 29, 2016

Profound Medical Corp. to Release First Quarter 2016 Financial Results on May 6, 2016

April 29, 2016

Profound Medical Corp. Announces World’s First Sale of TULSA-PRO for Prostate Ablation

April 28, 2016

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO

April 11, 2016

Best Poster at EAU 2016 Munich for the session, Localized prostate cancer: Innovative strategies in active surveillance and focal therapy

March 12, 2016

Profound Medical Corp. and Siemens Enter Into Strategic Agreement to Further the Development of Prostate Cancer Care

February 29, 2016

Profound Medical Corp. to Release Full Year 2015 Financial Results on March 3, 2016

February 25, 2016

Profound Medical Corp., Announces Publication in European Urology

January 8, 2016, Press Release

Profound Medical named 2016 Life Science Company of the Year

November 27, 2015, Press Release

A Brighter Future: Advancements in Prostate Therapy Minimize Side Effects for Patients

November 20, 2015, Media Planet Supplement, Toronto Star

Profound Medical Corp. Announces Departure of CFO

November 17, 2015, Press Release 

Things to Consider When Going Public

OnBoard Magazine Fall 2015

Profound Medical Corp. Announces Third Quarter 2015 Financial Results

November 4, 2015, Press Release

Hartmut Warnken joins Profound Medical as Vice President, International Sales

November 2, 2015, Press Release

Profound Medical Corp. to Release Third Quarter 2015 Financial Results on November 4, 2015

October 28, 2015, Press Release

Profound Medical to Present at Upcoming Investor Conferences

October 21, 2015, Press Release

Profound Medical Presents Successful 12-Month Phase 1 Outcomes at the European Symposium on Focused Ultrasound Therapy

October 15, 2015, Press Release

Profound Medical to Present 12-month outcomes of Phase 1 Clinical Trial at European Symposium on Focused Ultrasound Therapy News

October 13, 2015, Press Release

Profound Medical Announces Grant of Share Options

September 18, 2015, Press Release

Profound Medical Corp. Announces Second Quarter 2015 Financial Results

August 25, 2015, Press Release

Profound Medical Corp. Announces First Quarter 2015 Financial Results of Profound Medical Inc.

July 29, 2015, Press Release

Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients

July 21, 2015, Press Release

Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results

June 23, 2015, Press Release

Profound Medical Opens the Market

June 15, 2015, Press Release

Profound Medical Goes Public via Reverse Takeover

June 1, Biotechnology Focus

Profound Medical Corp. Announces Closing of Qualifying Transaction

June 4, 2015, Press Release

Preclinical safety and feasibility with 28-day follow-up

May 2015, Journal of Urology, Vol. 192

Profound Medical seeking CE Mark for TULSA-PRO This Year

May 26, 2015, Bio Tuesdays

Profound Medical and Shopify show Contrasting Ways to go Public

May 25, 2015, Financial Post

Mira IV Acquisition Corp. Announces Filing of Filing Statement

May 25, 2015, Press Release

PMI Announces Going-Public Transaction and Concurrent $28 Million Financing to Fund Next Stage of Growth

April 30, 2015, Press Release

Mira IV Acquisition Corp. Announces entering into of an Amalgamation Agreement with PMI

April 29, 2105, Press Release

CEO Steve Plymale participates in panel: Meet the Entrepreneurs – Health

April 15, 2015, MaRS video

Tips for Working with the FDA

OnBoard Magazine, Page 23, Spring 2015

Best Poster for Session, New Technologies in the OR, EAU 2015

March 2015, EAU Madrid

Newsroom2x

Upcoming Events

Meet Profound Medical at these Upcoming Meetings and Conferences

seperator-profound-sm

Annual Society of Thermal Medicine Meeting, Tucson

May 7-10, 2018

German Radiology Congress (RöKo), Leipzig

May 9-12, 2018

International Symposium for Therapeutic Ultrasound (ISTU), Nashville

May 14-17, 2018

American Urological Association Annual Meeting (AUA), San Francisco

May 18-21, 2018

106734A